I stopped fin for 6 months because of a porn addiction Finasteride/Dutasteride 1/20/2025
The user stopped taking finasteride due to erectile dysfunction, which they later realized was caused by excessive porn use and not the medication. They resumed finasteride, added dutasteride, and are using minoxidil and microneedling to regain hair.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Microneedling and minoxidil alone
A physician experienced hair thickening and new growth using microneedling and minoxidil, but stopped using topical finasteride due to side effects like reduced libido and erectile dysfunction. The physician plans to continue with microneedling and minoxidil, considering finasteride nonessential for cosmetic purposes.
community Experiencing No Progress with Minoxidil and Finasteride at 23
A 23-year-old male is experiencing no progress with hair loss despite using oral minoxidil and finasteride, and is considering dutasteride. He also reports experiencing erectile dysfunction, possibly due to starting lexapro.
community I was wrong about Dutastride. Let the I told you so comments rain in.
Switching from dutasteride to finasteride caused increased hair loss, dandruff, depression, and erectile dysfunction. The user plans to return to dutasteride, possibly with minoxidil, and is considering dosing strategies to manage side effects and regrowth.
community 10+ long year fin users share your story
Long-term finasteride users report maintaining or regrowing hair, often using additional treatments like minoxidil, low-level laser therapy, and ketoconazole shampoo. Most experience minimal side effects, though some report issues like erectile dysfunction.
community 32M, Grade 2-3 Hair Loss, Can’t Use Finasteride or Minoxidil Due to Side Effects and Psoriasis
A 32-year-old male with hair loss cannot use finasteride due to erectile dysfunction and minoxidil due to scalp psoriasis. He seeks alternative treatments for his condition.
Related Research
6 / 6 resultsresearch Risk associated with the use of 5-alpha reductase inhibitors with minoxidil in treatment of male androgenetic alopecia – literature review
This source reports that combining 5-alpha reductase inhibitors with minoxidil for treating male androgenic alopecia presents a minimal risk of side effects when administered following established medical guidelines, with finasteride commonly associated with reversible sexual side effects and dutasteride used off-label with similar risks.
research Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
This review discusses treatment options for androgenetic alopecia, highlighting the need for personalized, evidence-based approaches but reports no new clinical results.
research Safety concerns when using novel medications to treat alopecia
This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.
research Androgenetic Alopecia: Therapy Update
This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.
research A review of the treatment of male pattern hair loss
This review discusses pharmacologic and non-pharmacologic treatments for androgenetic alopecia, noting that current medications like finasteride and minoxidil can slow hair loss but only partially restore hair growth, with early treatment offering better outcomes.
research Cosmetic Approach for Men
This chapter reviews differences in dermatological treatments and conditions between male and female patients, particularly noting the impacts of sex steroids on various skin processes, but presents no new clinical findings.